Assesment of the Covid-19 pandemic

Last registered on October 17, 2022
View Trial History

Pre-Trial

Trial Information

General Information

Title
Assesment of the Covid-19 pandemic
RCT ID
AEARCTR-0009646
Initial registration date
October 11, 2022

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
October 17, 2022, 5:22 PM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Locations

Country
Argentina
Region
Córdoba province

Primary Investigator

Name
Rafael Di Tella
Affiliation
Harvard Business School
Contact Primary Investigator

Other Primary Investigator(s)

PI Name
Sebastian Calonico
PI Affiliation
Department of Health Policy and Management Columbia University
Contact Investigator
PI Name
Juan Cruz Lopez Del Valle
PI Affiliation
Boston University
Contact Investigator

Additional Trial Information

Status
Completed
Start date
2022-09-19
End date
2022-10-14
Keywords
Behavior, Electoral, Governance, Health
Additional Keywords
Political economy, beliefs
JEL code(s)
I1, I18, O3
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
The objective of this research is to understand why people supports a "miracle cure", how they learn about the value of this new medical technology and if there is influence of sociodemographic factors. This will be carried through an online survey Argentina. The information available to respondents will be varied using experimental treatments.
External Link(s)

Registration Citation

Citation
Calonico, Sebastian, Rafael Di Tella and Juan Cruz Lopez Del Valle. 2022. "Assesment of the Covid-19 pandemic." AEA RCT Registry. October 17. https://doi.org/10.1257/rct.9646-1.0
Sponsors & Partners
Experimental Details

Interventions

Intervention(s)
We will run an in-person survey in three provinces of Argentina. The assigment will have the title (in spanish): "Assesment of the COVID-19 pandemic". The subjects will participate in a raffle for a voucher of the equivalent in argentinean pesos of $300. Respondents’ answers will be fully anonymous: no identifiable information, whether name, address, or contact information, will be collected. Respondents will be invited to participate in the study and will be informed of its anonymity through a consent form.

To begin with, participants will answer some socioeconomic and background questions. After that, respondents will be randomly selected into one of 4 groups. Each group will receive different pieces of information regarding treatments against COVID-19 used in Argentina during the pandemic (see the questionnaire). Laslty, we will make them answer questions about outcomes of interest.

The survey should take about 10 minutes to complete.
Intervention Start Date
2022-09-19
Intervention End Date
2022-10-14

Primary Outcomes

Primary Outcomes (end points)
Support for nebulized ibuprofen, action in favor (or against) nebulizer ibuprofen
Primary Outcomes (explanation)
Questions detailed in the survey:

https://www.questionpro.com/a/TakeSurvey?tt=tpm3QEqkgBMECHrPeIW9eQ%3D%3D

Secondary Outcomes

Secondary Outcomes (end points)
Policy preferences, positions towards science
Secondary Outcomes (explanation)
Questions detailed in the survey

Experimental Design

Experimental Design
We will run an in-person survey in three provinces of Argentina. The assigment will have the title (in spanish): "Assesment of the COVID-19 pandemic". The subjects will participate in a raffle for a voucher of the equivalent in argentinean pesos of $300. Respondents’ answers will be fully anonymous: no identifiable information, whether name, address, or contact information, will be collected. Respondents will be invited to participate in the study and will be informed of its anonymity through a consent form.

To begin with, participants will answer some socioeconomic and background questions. After that, respondents will be randomly selected into one of 4 groups. Each group will receive different pieces of information regarding treatments against COVID-19 used in Argentina during the pandemic (see the questionnaire). Laslty, we will make them answer questions about outcomes of interest.

The survey should take about 10 minutes to complete.
Experimental Design Details
Randomization Method
Randomization done by an algorithm
Randomization Unit
Individual
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
3,200 individuals
Sample size: planned number of observations
3,200 individuals
Sample size (or number of clusters) by treatment arms
800 individuals
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
Supporting Documents and Materials
IRB

Institutional Review Boards (IRBs)

IRB Name
Harvard Human Research Protection Program
IRB Approval Date
2022-09-04
IRB Approval Number
IRB22-1163
Analysis Plan

Post-Trial

Post Trial Information

Study Withdrawal

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Intervention

Is the intervention completed?
No
Data Collection Complete
Data Publication

Data Publication

Is public data available?
No

Program Files

Program Files
Reports, Papers & Other Materials

Relevant Paper(s)

Reports & Other Materials